To identify the downstream targets implicated in inhibiting tumor progression of xenograft models CD90 positive after Crenigacestat treatment, we used a commercially PCR array with 40 genes involved in the AKT signaling, frequently coactivated with NOTCH signaling in human iCCA [18–20]. Here, AKT1 is linked to neoplasm.